These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3465171)

  • 21. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
    Deslauriers JR; Lenz AM; Root AW; Diamond FB; Bercu BB
    J Pediatr Endocrinol Metab; 2012; 25(9-10):977-81. PubMed ID: 23426829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP; Winter A; Stolecke H
    Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Puberty and adult height in congenital virilizing adrenal hyperplasia (author's transl)].
    Himon F; Job JC; Pierson M; Canlorbe P
    Sem Hop; 1981 Oct 8-15; 57(37-38):1488-93. PubMed ID: 6270813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S; Sellers EA; Guyda H;
    J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors determining final height in congenital adrenal hyperplasia.
    New MI;
    J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():933-7. PubMed ID: 11529398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC; Grant DB
    Acta Paediatr; 1995 Aug; 84(8):899-903. PubMed ID: 7488814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE; Sizonenko PC
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth characteristics in children with congenital adrenal hyperplasia.
    Alzanbagi MA; Milyani AA; Al-Agha AE
    Saudi Med J; 2018 Jul; 39(7):674-678. PubMed ID: 29968889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Patel L; Chandrashekhar SR; Gemmell I; O'Shea E; Jones J; Banerjee I; Amin R; Clayton P
    Horm Res Paediatr; 2011; 75(3):206-12. PubMed ID: 20962509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth and development in children with classic congenital adrenal hyperplasia.
    Bonfig W
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):39-42. PubMed ID: 27898585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring treatment in congenital adrenal hyperplasia.
    Appan S; Hindmarsh PC; Brook CG
    Arch Dis Child; 1989 Sep; 64(9):1235-9. PubMed ID: 2640553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W; Kaufhold A; Willgerodt H; Keller E
    Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
    Bonfig W; Roehl F; Riedl S; Brämswig J; Richter-Unruh A; Fricke-Otto S; Hübner A; Bettendorf M; Schönau E; Dörr H; Holl RW; Mohnike K
    Horm Res Paediatr; 2018; 89(1):7-12. PubMed ID: 29073619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
    Bonfig W; Schwarz HP
    J Pediatr Endocrinol Metab; 2012; 25(7-8):645-9. PubMed ID: 23155688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Growth and adult height in patients with congenital adrenal hyperplasia].
    Kolousková S; Zemková D; Snajderová M; Lebl J
    Cas Lek Cesk; 1995 Nov; 134(21):689-91. PubMed ID: 8556761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
    Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Dörr HG
    Horm Res; 2007; 68 Suppl 5():93-9. PubMed ID: 18174719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L; Nimkarn S; New MI; Lin-Su K
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):883-91. PubMed ID: 17937061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Final height of patients with classical congenital adrenal hyperplasia.
    Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
    Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.